Pfizer, which currently holds a 32% stake in Haleon, said last May it planned to cut its ownership in a “slow and methodical” manner within months.
Pfizer, which currently holds a 32% stake in Haleon, said last May it planned to cut its ownership in a “slow and methodical” manner within months.